These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16140827)

  • 1. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
    Lieberman JR; Hsu WK
    J Bone Joint Surg Am; 2005 Sep; 87(9):2097-112. PubMed ID: 16140827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolic prophylaxis after elective total hip arthroplasty.
    Conduah A; Lieberman JR
    Clin Orthop Relat Res; 2005 Dec; 441():274-84. PubMed ID: 16331015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
    Eikelboom JW; Quinlan DJ; Douketis JD
    Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
    Lieberman JR; Pensak MJ
    J Bone Joint Surg Am; 2013 Oct; 95(19):1801-11. PubMed ID: 24088973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's New in Venous Thromboembolic Prophylaxis Following Total Knee and Total Hip Arthroplasty? An Update.
    Pierce TP; Elmallah RK; Jauregui JJ; Cherian JJ; Mont MA
    Surg Technol Int; 2015 May; 26():234-7. PubMed ID: 26055015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
    Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership.
    Mesko JW; Brand RA; Iorio R; Gradisar I; Heekin R; Leighton R; Thornberry R
    J Arthroplasty; 2001 Sep; 16(6):679-88. PubMed ID: 11547365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism in high-risk surgical and medical patients.
    Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
    Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
    Patel VP; Walsh M; Sehgal B; Preston C; DeWal H; Di Cesare PE
    J Bone Joint Surg Am; 2007 Jan; 89(1):33-8. PubMed ID: 17200307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of discharge and two-week duplex ultrasound screening protocols for deep venous thrombosis detection following primary total joint arthroplasty.
    Dhupar S; Iorio R; Healy WL; Dhimitri K
    J Bone Joint Surg Am; 2006 Nov; 88(11):2380-5. PubMed ID: 17079394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism after a total hip arthroplasty: prevention and treatment.
    Berry DJ
    Instr Course Lect; 2003; 52():275-80. PubMed ID: 12690855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
    Anderson FA; Hirsh J; White K; Fitzgerald RH;
    Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations.
    Miric A; Lombardi P; Sculco TP
    Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.